The role of antibiotic prophylaxis in totally implantable venous access device placement: Results of a single-center prospective randomized trial

American Journal of Surgery

Volumn 202, Issue 1, 2011, Pages 10-15

  Karanlik, Hasan ^a   Kurul, Sidika ^a   Saip, Pinar ^a   Unal, Ersin Selcuk ^a   Sen, Fatma ^a   Disci, Rian ^a   Topuz, Erkan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antibiotic prophylaxis; Infection rate; Totally implantable venous access device

Indexed keywords

CEFAZOLIN; PLACEBO;

ADULT; ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DEBRIDEMENT; DEEP SURGICAL SITE INFECTION; FEMALE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS; SUPERFICIAL SURGICAL SITE INFECTION; SURGICAL INFECTION; TOTALLY IMPLANTABLE VENOUS ACCESS DEVICE; VASCULAR ACCESS DEVICE;

EID: 79960200437     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.05.005     Document Type: Article

References (22)

1. P. Samaras, S. Dold, and J. Braun Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients Oncology 74 2008 237 244
2. H. Karanlik, and S. Kurul Modification of approach for totally implantable venous access device decreases rate of complications J Surg Oncol 100 2009 279 283
3. R.P. Sticca, B.D. Dewing, and J.D. Harris Outcomes of surgical and radiologic placed implantable central venous access ports Am J Surg 198 2009 829 833
4. J.T. Carlo, J.P. Lamont, and T.M. McCarty A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports Am J Surg 188 2004 722 727
5. G.A. Goossens, M. Vrebos, and M. Stas Central vascular access devices in oncology and hematology considered from a different point of view: how do patients experience their vascular access ports? J Infus Nurs 28 2005 61 67 (Pubitemid 40224000)
6. R. Biffi, F. Orsi, and S. Pozzi Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial Ann Oncol 20 2009 935 940
7. T.J. Aufenacker, M.J. Koelemay, and D.J. Gouma Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia Br J Surg 93 2006 5 10 (Pubitemid 43117298)
8. M. Cunningham, F. Bunn, and K. Handscomb Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery Cochrane Database Syst Rev 2 2006 CD005360
9. S. Kurul, P. Saip, and T. Aydin Totally implantable venous-access ports: local problems and extravasation injury Lancet Oncol 3 2002 684 692 (Pubitemid 35314912)
10. S. Vescia, A.K. Baumgrtner, and V.R. Jacobs Management of venous port systems in oncology: a review of current evidence Ann Oncol 19 2008 9 15
11. B. Yildizeli, T. Lain, and H.F. Batirel Complications and management of long-term central venous access catheters and ports J Vasc Access 5 2004 174 178 (Pubitemid 41158317)
12. H.J. Kock, M. Pietsch, and U. Krause Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems World J Surg 22 1998 12 16 (Pubitemid 28027994)
13. R.E. Schwarz, J.S. Groeger, and D.G. Coit Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis Cancer 79 1997 1635 1640 (Pubitemid 27154800)
14. E.D. Whitman, and A.M. Boatman Comparison of diagnostic specimens and methods to evaluate infected venous access ports Am J Surg 170 1995 665 670
15. A.J. Mangram, T.C. Horan, and M.L. Pearson Guideline for prevention of surgical site infection; 1999 Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee Am J Infect Control 27 1999 97 132
16. C. Young, and J.R. Gould The timing and sequence of multiple device-related complications in patients with indwelling subcutaneous ports Am J Surg 174 1997 417 421 (Pubitemid 27444172)
17. Biffi R, de Braud F, Orsi F. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 1998l;9:76773.
18. G. Ftkenheuer, D. Buchheidt, and O.A. Cornely Central venous catheter (CVC)-related infections in neutropenic patients Ann Hematol 82 2003 149 157
19. E. Bouza, A. Burillo, and P. Muoz Catheter-related infections: diagnosis and intravascular treatment Clin Microbiol Infect 8 2002 265 274 (Pubitemid 34993797)
20. K. Hall, and B. Farr Diagnosis and management of long-term central venous catheter infections J Vasc Interv Radiol 15 2004 327 334 (Pubitemid 38451975)
21. M.C. Douard, G. Arlet, and P. Longuet Diagnosis of venous access port-related infections Clin Infect Dis 29 1999 1197 1202 (Pubitemid 30265639)
22. N.P. O'Grady, M. Alexander, and E.P. Dellinger Guidelines for the prevention of intravascular catheter-related infections Am J Infect Control 30 2002 476 489 (Pubitemid 36009080)